The effects on known targets of ETSP on GBM cells and their growth in vivo were studied using multiple GBM-derived cell lines and primary cultures, as well as high MMP2-expressing cell lines of cervical cancer, stroma of prostate cancer and metastatic prostate cancer, and three orthotopic GBM xenograft models. The gene discussed is MMP2; the disease is glioblastoma.